Abstract:BACKGROUND & OBJECTIVE:Tumor necrosis factor alpha (TNF-alpha) is an important agent for tumor biotherapy because of its strong antitumor activity, but its clinical application is limited because of its severe fatal systemic toxicity. A new recombinant human (rh) mutein, mutant type (mt) 471rhTNF-alpha, was produced to decrease toxicity while keep antitumor activity of wild type (wt) TNF-alpha. This study was to compare the antitumor activities of mt-471rhTNF-alpha and wt-rhTNF-alpha, and analyze the mechanism of tumor cell apoptosis induced by mt-471rhTNF-alpha.METHODS:Breast cancer cell line ZR75-1 was treated with 100 microg/L of mt-471rhTNF-alpha or wt-rhTNF-alpha for 12 h. Cell apoptosis was analyzed with 2% agarose gel electrophoresis, and cell cycle distribution was analyzed by flow cytometry. The activation of nuclear factor-kappaB (NF-kappaB) p65 in ZR75-1 cells treated with 10 microg/L, 50 microg/L, and 100 microg/L of mt-471rhTNF-alpha or wt-rhTNF-alpha for 4 h were detected using Trans AMTM NF-kappaB p65 kit based on ELISA.RESULTS:ZR75-1 cells treated with mt-471rhTNF-alpha had typical ladders of DNA fragmentation, whereas ZR75-1 cells treated with wt-rhTNF-alpha only had weak ladders; the apoptosis rate of ZR75-1 cells was significantly higher in mt-471rhTNF-alpha group than in wt-rhTNF-alpha group [(44.6+/-3.6)% vs. (24.7+/-2.7)%, P<0.05]. The proportion of G1 phase cells was significantly higher in mt-471rhTNF-alpha group than in control group and wt-rhTNF-alpha group [(66.6+/-4.2)% vs. (34.8+/-3.1)% and (46.2+/-3.8)%, P<0.05]; the proportions of S phase and G2 phase cells were significantly lower in mt-471rhTNF-alpha group than in control group and wt-rhTNF-alpha group [(33.2+/-2.9)% vs. (50.1+/-3.8)% and (45.7+/-2.9)%, P<0.05; (0.2+/-0.0)% vs. (15.1+/-2.2)% and (8.1+/-3.1)%, P<0.05]. When treated with 50 microg/L rhTNF-alpha for 4 h, NF-kappaB activation was significantly higher in wt-rhTNF-alpha group than in mt-471rhTNF-alpha group (3.3+/-0.1 vs. 1.5+/-0.2, P<0.05 ).CONCLUSIONS:The antitumor ability of mt-471rhTNF-alpha is more stronger than that of wt-rhTNF-alpha. The explanation for the enhanced apoptosis-inducible ability of mt-471rhTNF-alpha could be that NF-kappaB activation is inhibited in tumor cells treated with mt-471rhTNF-alpha.

Dimerization of Chimeric Erythropoietin/75 Kda Tumour Necrosis Factor (TNF) Receptors Transduces TNF Signals: Necessity for the 75 Kda-Tnf Receptor Transmembrane Domain.

Chimeric Tumor Necrosis Factor Receptors with Constitutive Signaling Activity.

The Diversity and Similarity of Transmembrane Trimerization of TNF Receptors

Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF

A Tumor Necrosis Factor (TNF) Receptor-Igg Heavy Chain Chimeric Protein As a Bivalent Antagonist of TNF Activity.

Fusion Protein of CDR Mimetic Peptide with Fc Inhibit TNF-α Induced Cytotoxicity

Knockout of the Tumor Necrosis Factor a Receptor 1 Gene Can Up-Regulate Erythropoietin Receptor During Myocardial Ischemia-Reperfusion Injury in Mice.

Development of a Chimaeric Receptor Approach to Study Signalling by Tumour Necrosis Factor Receptor Family Members.

Ligand-induced Activation of Chimeric Receptors Between the Erythropoietin Receptor and Receptor Tyrosine Kinases.

Dual Regulation Of Soluble Tumor Necrosis Factor-Alpha Induced Activation Of Human Monocytic Cells Via Modulating Transmembrane Tnf-Alpha-Mediated 'Reverse Signaling'

Differential Role of TNF Receptors in Cellular Trafficking of Intact TNF.

Comparison of the cytocidal effect induced by transmembrane and secreted TNF-alpha

Trivalent Soluble TNF Receptor, a Potent TNF-α Antagonist for the Treatment Collagen-Induced Arthritis.

Production of Bioactive, SUMO-modified, and Native-Like TNF-α of the Rhesus Monkey, Macaca Mulatta , in Escherichia Coli

[Inducement Effect of Recombinant Human TNF-alpha on Apoptosis of Breast Cancer Cell Line ZR75-1 and Its Mechanism].

Covalently dimerized Camelidae antihuman TNFa single-domain antibodies expressed in yeast Pichia pastoris show superior neutralizing activity

Hydrophobic cavity in C-terminus is essential for hTNF-α trimer conformation.

Ligand-independent Signaling by Disulfide-Crosslinked Dimers of the P75 Neurotrophin Receptor

Equilibrium Between Monomers and Dimers of the Death Domain of the P75 Neurotrophin Receptor in Solution.

Preparation and identification of transmembrane TNF-α(TM-TNF-α)specific monoclonal antibody

Construction of Eukaryotic Expression Vector of Wild-type/Transmembrane TNF and The Effect on Cardiomyocyte Apoptosis